Jupiter Pfcf Ratio vs Book Value Per Share Analysis

JUNS Stock

USD 9.73 1.13 10.41%

Jupiter Neurosciences, financial indicator trend analysis is infinitely more than just investigating Jupiter Neurosciences, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jupiter Neurosciences, is a good investment. Please check the relationship between Jupiter Neurosciences, Pfcf Ratio and its Book Value Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jupiter Neurosciences, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pfcf Ratio vs Book Value Per Share

Pfcf Ratio vs Book Value Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jupiter Neurosciences, Pfcf Ratio account and Book Value Per Share. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Jupiter Neurosciences,'s Pfcf Ratio and Book Value Per Share is -0.27. Overlapping area represents the amount of variation of Pfcf Ratio that can explain the historical movement of Book Value Per Share in the same time period over historical financial statements of Jupiter Neurosciences, Common, assuming nothing else is changed. The correlation between historical values of Jupiter Neurosciences,'s Pfcf Ratio and Book Value Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pfcf Ratio of Jupiter Neurosciences, Common are associated (or correlated) with its Book Value Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Book Value Per Share has no effect on the direction of Pfcf Ratio i.e., Jupiter Neurosciences,'s Pfcf Ratio and Book Value Per Share go up and down completely randomly.

Correlation Coefficient

-0.27

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Pfcf Ratio

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Most indicators from Jupiter Neurosciences,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jupiter Neurosciences, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jupiter Neurosciences, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Sales General And Administrative To Revenue is likely to gain to 11.03 in 2024, whereas Selling General Administrative is likely to drop slightly above 2.8 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	638.0K	233.3K	210.0K	199.5K
Total Revenue	638.0K	233.3K	210.0K	199.5K

Gross Profit Total Revenue

Jupiter Neurosciences, fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total
Total Assets		-0.89	0.09	-0.76	0.8	-0.9	0.92	0.98	0.98	0.98	0.79	-0.92	0.89	-0.87	-0.76	0.95	-0.9	-0.93	0.97	0.97	0.79	0.17
Short Long Term Debt Total	-0.89		0.23	0.89	-0.93	1.0	-0.93	-0.92	-0.79	-0.79	-0.61	0.98	-0.97	0.97	0.9	-0.97	1.0	0.98	-0.92	-0.92	-0.61	-0.27
Other Current Liab	0.09	0.23		0.53	-0.47	0.21	-0.03	-0.06	0.19	0.19	0.4	0.16	-0.24	0.04	0.52	-0.14	0.23	0.21	0.12	0.12	0.4	-0.82
Total Current Liabilities	-0.76	0.89	0.53		-1.0	0.88	-0.86	-0.86	-0.63	-0.63	-0.53	0.83	-0.94	0.79	1.0	-0.91	0.89	0.87	-0.76	-0.76	-0.53	-0.53
Total Stockholder Equity	0.8	-0.93	-0.47	-1.0		-0.92	0.89	0.89	0.69	0.69	0.56	-0.88	0.97	-0.83	-1.0	0.94	-0.93	-0.91	0.81	0.81	0.56	0.49
Net Debt	-0.9	1.0	0.21	0.88	-0.92		-0.92	-0.92	-0.82	-0.82	-0.6	0.99	-0.96	0.97	0.88	-0.96	1.0	0.99	-0.93	-0.93	-0.6	-0.28
Retained Earnings	0.92	-0.93	-0.03	-0.86	0.89	-0.92		0.95	0.82	0.82	0.85	-0.89	0.98	-0.94	-0.87	0.98	-0.93	-0.89	0.97	0.97	0.85	0.08
Accounts Payable	0.98	-0.92	-0.06	-0.86	0.89	-0.92	0.95		0.93	0.93	0.78	-0.93	0.95	-0.88	-0.86	0.98	-0.93	-0.94	0.95	0.95	0.78	0.27
Cash	0.98	-0.79	0.19	-0.63	0.69	-0.82	0.82	0.93		1.0	0.74	-0.86	0.78	-0.77	-0.63	0.87	-0.81	-0.87	0.9	0.9	0.74	0.17
Cash And Short Term Investments	0.98	-0.79	0.19	-0.63	0.69	-0.82	0.82	0.93	1.0		0.74	-0.86	0.78	-0.77	-0.63	0.87	-0.81	-0.87	0.9	0.9	0.74	0.17
Net Receivables	0.79	-0.61	0.4	-0.53	0.56	-0.6	0.85	0.78	0.74	0.74		-0.58	0.72	-0.69	-0.54	0.76	-0.6	-0.57	0.84	0.84	1.0	-0.29
Common Stock Shares Outstanding	-0.92	0.98	0.16	0.83	-0.88	0.99	-0.89	-0.93	-0.86	-0.86	-0.58		-0.93	0.95	0.84	-0.95	0.99	1.0	-0.93	-0.92	-0.58	-0.29
Other Current Assets	0.89	-0.97	-0.24	-0.94	0.97	-0.96	0.98	0.95	0.78	0.78	0.72	-0.93		-0.93	-0.95	0.99	-0.97	-0.94	0.93	0.93	0.72	0.27
Other Stockholder Equity	-0.87	0.97	0.04	0.79	-0.83	0.97	-0.94	-0.88	-0.77	-0.77	-0.69	0.95	-0.93		0.8	-0.93	0.97	0.92	-0.95	-0.95	-0.69	-0.03
Total Liab	-0.76	0.9	0.52	1.0	-1.0	0.88	-0.87	-0.86	-0.63	-0.63	-0.54	0.84	-0.95	0.8		-0.91	0.9	0.87	-0.77	-0.77	-0.54	-0.5
Total Current Assets	0.95	-0.97	-0.14	-0.91	0.94	-0.96	0.98	0.98	0.87	0.87	0.76	-0.95	0.99	-0.93	-0.91		-0.97	-0.96	0.96	0.96	0.76	0.25
Short Term Debt	-0.9	1.0	0.23	0.89	-0.93	1.0	-0.93	-0.93	-0.81	-0.81	-0.6	0.99	-0.97	0.97	0.9	-0.97		0.98	-0.93	-0.92	-0.6	-0.29
Common Stock	-0.93	0.98	0.21	0.87	-0.91	0.99	-0.89	-0.94	-0.87	-0.87	-0.57	1.0	-0.94	0.92	0.87	-0.96	0.98		-0.91	-0.91	-0.57	-0.37
Property Plant And Equipment Net	0.97	-0.92	0.12	-0.76	0.81	-0.93	0.97	0.95	0.9	0.9	0.84	-0.93	0.93	-0.95	-0.77	0.96	-0.93	-0.91		1.0	0.84	0.01
Non Current Assets Total	0.97	-0.92	0.12	-0.76	0.81	-0.93	0.97	0.95	0.9	0.9	0.84	-0.92	0.93	-0.95	-0.77	0.96	-0.92	-0.91	1.0		0.84	0.01
Non Currrent Assets Other	0.79	-0.61	0.4	-0.53	0.56	-0.6	0.85	0.78	0.74	0.74	1.0	-0.58	0.72	-0.69	-0.54	0.76	-0.6	-0.57	0.84	0.84		-0.29
Non Current Liabilities Total	0.17	-0.27	-0.82	-0.53	0.49	-0.28	0.08	0.27	0.17	0.17	-0.29	-0.29	0.27	-0.03	-0.5	0.25	-0.29	-0.37	0.01	0.01	-0.29

Click cells to compare fundamentals

Jupiter Neurosciences, Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Jupiter Stock Analysis

When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jupiter Pfcf Ratio vs Book Value Per Share Analysis

Pfcf Ratio vs Book Value Per Share

Pfcf Ratio vs Book Value Per Share Correlation Analysis

Correlation Coefficient

Pfcf Ratio

Book Value Per Share

Jupiter Neurosciences, fundamental ratios Correlations

Jupiter Neurosciences, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Jupiter Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Short Term Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities
Short Term Debt	+ 1.0	Net Debt
Cash And Short Term Investments	+ 1.0	Cash
Non Currrent Assets Other	+ 1.0	Net Receivables

Total Liab	- 1.0	Total Stockholder Equity
Total Stockholder Equity	- 1.0	Total Current Liabilities
Short Term Debt	- 0.97	Total Current Assets
Short Term Debt	- 0.97	Other Current Assets
Total Current Assets	- 0.97	Short Long Term Debt Total
Other Current Assets	- 0.97	Short Long Term Debt Total